Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05790057
What this trial is testing

Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )

Who this might be right for
Liver Steatoses
Assiut University 60
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Not applicableLooking for participantsNCT06591169
What this trial is testing

Lifestyle Changes in PCOS with OSA and NAFLD

Who this might be right for
PCOSNAFLDOSA
Cairo University 40
Not applicableUnknownNCT06413069
What this trial is testing

Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)

Who this might be right for
PreDiabetesNAFLD
Charite University, Berlin, Germany 150
Not applicableStudy completedNCT03526445
What this trial is testing

Hepatic Metabolic Changes in Response to Glucagon Infusion

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseTotal PancreatectomyDiabetes Mellitus
Steno Diabetes Center Copenhagen 27
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Not applicableNot Yet RecruitingNCT07730853
What this trial is testing

Isocaloric Navy-Bean Substitution in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Icahn School of Medicine at Mount Sinai 40
Not applicableStudy completedNCT03432377
What this trial is testing

Coffee Consumption and NASH in the French Population.

Who this might be right for
Non Alcoholic Steatohepatitis
Versailles Hospital 107
Not applicableUnknownNCT03481465
What this trial is testing

Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis

Who this might be right for
SchizophreniaPsychosisMetabolic Syndrome
Fundación Marques de Valdecilla 200
Not applicableNot Yet RecruitingNCT06668753
What this trial is testing

Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Who this might be right for
Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Assiut University 114
Not applicableActive Not RecruitingNCT04707651
What this trial is testing

Formula Diet Treatment for NASH Patients.

Who this might be right for
Steatohepatitis, Nonalcoholic
West German Center of Diabetes and Health 20
Not applicableLooking for participantsNCT05546086
What this trial is testing

BeijngFH Health Cohort Study

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Beijing Friendship Hospital 8,103
Testing effectiveness (Phase 2)Study completedNCT00266019
What this trial is testing

Weight Management in Nonalcoholic Steatohepatitis

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Early research (Phase 1)Study completedNCT03744182
What this trial is testing

Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD

Who this might be right for
NAFLD
Hanmi Pharmaceutical Company Limited 66
Testing effectiveness (Phase 2)Ended earlyNCT04378010
What this trial is testing

A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

Who this might be right for
Non-Alcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 98
Not applicableStudy completedNCT02784925
What this trial is testing

Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement

Who this might be right for
Fatty Liver
Taipei Medical University WanFang Hospital 30
Early research (Phase 1)Study completedNCT04692025
What this trial is testing

Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers

Who this might be right for
HealthyNAFLDHyperlipidemia
Gannex Pharma Co., Ltd. 12
Not applicableUnknownNCT04985188
What this trial is testing

Quantitative Ultrasound for Diagnosing Hepatic Steatosis in Nonalcoholic Fatty Liver Multicenter Study

Who this might be right for
Diagnoses Disease
Seoul National University Hospital 112
Testing effectiveness (Phase 2)Study completedNCT02126306
What this trial is testing

Beta Glucosylceramide for Treatment of NASH

Who this might be right for
Compliance Behavior
Hadassah Medical Organization 23
Next Page